Name | Number of supported studies | Average coverage | |
---|---|---|---|
type I pneumocyte | 6 studies | 25% ± 7% | |
endothelial cell | 6 studies | 21% ± 3% |
Insufficient scRNA-seq data for expression of ATOH8 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
thymus | 100% | 10110.39 | 653 / 653 | 91% | 31.41 | 552 / 605 |
prostate | 96% | 3435.84 | 235 / 245 | 77% | 6.68 | 387 / 502 |
skin | 83% | 2772.96 | 1495 / 1809 | 57% | 5.58 | 267 / 472 |
lung | 98% | 4491.94 | 567 / 578 | 40% | 6.06 | 462 / 1155 |
bladder | 100% | 3447.24 | 21 / 21 | 28% | 3.91 | 140 / 504 |
liver | 84% | 2435.63 | 190 / 226 | 42% | 4.04 | 170 / 406 |
brain | 26% | 405.22 | 681 / 2642 | 95% | 27.65 | 667 / 705 |
uterus | 98% | 3742.88 | 167 / 170 | 20% | 1.96 | 92 / 459 |
ovary | 95% | 2643.98 | 171 / 180 | 23% | 1.54 | 100 / 430 |
kidney | 54% | 1057.26 | 48 / 89 | 57% | 6.35 | 516 / 901 |
breast | 98% | 4857.70 | 449 / 459 | 7% | 0.42 | 77 / 1118 |
ureter | 0% | 0 | 0 / 0 | 100% | 21.82 | 1 / 1 |
blood vessel | 99% | 6968.41 | 1319 / 1335 | 0% | 0 | 0 / 0 |
adipose | 99% | 5044.12 | 1188 / 1204 | 0% | 0 | 0 / 0 |
muscle | 96% | 5811.48 | 770 / 803 | 0% | 0 | 0 / 0 |
heart | 94% | 3229.92 | 813 / 861 | 0% | 0 | 0 / 0 |
intestine | 76% | 1278.11 | 732 / 966 | 17% | 1.08 | 90 / 527 |
spleen | 90% | 2061.15 | 216 / 241 | 0% | 0 | 0 / 0 |
stomach | 68% | 1142.57 | 244 / 359 | 15% | 0.85 | 42 / 286 |
esophagus | 75% | 2015.34 | 1081 / 1445 | 6% | 0.30 | 11 / 183 |
eye | 0% | 0 | 0 / 0 | 51% | 2.71 | 41 / 80 |
pancreas | 9% | 95.09 | 28 / 328 | 21% | 1.41 | 38 / 178 |
adrenal gland | 3% | 34.00 | 9 / 258 | 13% | 0.94 | 31 / 230 |
tonsil | 0% | 0 | 0 / 0 | 16% | 1.70 | 7 / 45 |
lymph node | 0% | 0 | 0 / 0 | 10% | 0.50 | 3 / 29 |
peripheral blood | 1% | 15.61 | 12 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0010629 | Biological process | negative regulation of gene expression |
GO_0045603 | Biological process | positive regulation of endothelial cell differentiation |
GO_0010595 | Biological process | positive regulation of endothelial cell migration |
GO_0060391 | Biological process | positive regulation of SMAD protein signal transduction |
GO_0035148 | Biological process | tube formation |
GO_0001704 | Biological process | formation of primary germ layer |
GO_0001937 | Biological process | negative regulation of endothelial cell proliferation |
GO_0045893 | Biological process | positive regulation of DNA-templated transcription |
GO_0051450 | Biological process | myoblast proliferation |
GO_0030154 | Biological process | cell differentiation |
GO_1902895 | Biological process | positive regulation of miRNA transcription |
GO_0009653 | Biological process | anatomical structure morphogenesis |
GO_0045892 | Biological process | negative regulation of DNA-templated transcription |
GO_0007399 | Biological process | nervous system development |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0016607 | Cellular component | nuclear speck |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005737 | Cellular component | cytoplasm |
GO_0000785 | Cellular component | chromatin |
GO_0005634 | Cellular component | nucleus |
GO_0140297 | Molecular function | DNA-binding transcription factor binding |
GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
GO_0003700 | Molecular function | DNA-binding transcription factor activity |
GO_0070888 | Molecular function | E-box binding |
GO_0046983 | Molecular function | protein dimerization activity |
Gene name | ATOH8 |
Protein name | Transcription factor ATOH8 (Class A basic helix-loop-helix protein 21) (bHLHa21) (Helix-loop-helix protein hATH-6) (hATH6) (Protein atonal homolog 8) |
Synonyms | BHLHA21 ATH6 |
Description | FUNCTION: Transcription factor that binds a palindromic (canonical) core consensus DNA sequence 5'-CANNTG- 3' known as an E-box element, possibly as a heterodimer with other bHLH proteins . Regulates endothelial cell proliferation, migration and tube-like structures formation . Modulates endothelial cell differentiation through NOS3 . May be implicated in specification and differentiation of neuronal cell lineages in the brain (By similarity). May participate in kidney development and may be involved in podocyte differentiation (By similarity). During early embryonic development is involved in tissue-specific differentiation processes that are dependent on class II bHLH factors and namely modulates the differentiation program initiated by the pro-endocrine factor NEUROG3 (By similarity). During myogenesis, may play a role during the transition of myoblasts from the proliferative phase to the differentiation phase (By similarity). Positively regulates HAMP transcription in two ways, firstly by acting directly on the HAMP promoter via E-boxes binding and indirectly through increased phosphorylation of SMAD protein complex . Repress NEUROG3-dependent gene activation in a gene-specific manner through at least two mechanisms; requires only either the sequestering of a general partner such as TCF3 through heterodimerization, either also requires binding of the bHLH domain to DNA via a basic motif (By similarity). . |
Accessions | Q96SQ7 ENST00000306279.4 [Q96SQ7-1] |